stella
beta
Recruiting
Back to Carcinoma, Non-Small-Cell Lung trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shandong Public Health Clinical Center, Jinan, Shangdong
View full record on ClinicalTrials.gov
Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC — Stella